Monoclonal Antibodies Core FacilityCore Facilities
The activities of the EMBL Monoclonal Antibodies Core Facility (MACF) ceased at the end of August 2012. Under the lead of Alan Sawyer, the former head of MACF, the activities are being continued by Paratopes Ltd, an EMBL spin-off company in the UK.
Paratopes provides discretionary prices and discounts for the services it provides to EMBL scientists and members of the EMBO Young Investigators Programme (EMBO-YIP). Please contact Paratopes directly should you have need of custom monoclonal antibodies and further pricing details.